The Multiple Myeloma Research Consortium (MMRC) sent me a press release, touting the fact that, “The MMRC has opened more than 40 Phase I and Phase II clinical trials of both novel compounds and combination approaches that are thought to be active against high-priority targets.”
Impressive! The group has backed studies involving elotuzumab, Millennium’s oral proteasome inhibitor, MLN9708, Kyprolis and panobinostat, to name just a few.
All I can say is, “THANK YOU!”
Speaking of elotuzumab, the International Myeloma Foundation (IMF) sent me information about a pair of elotuzumab studies which are currently enrolling:
Moving on, a large study done in the UK came to the conclusion that organic food is no better for us than the mass produced milk, meet and produce found on grocer’s shelves.
Dr. Joseph Mercola, a well known but controversial nutritional expert, strongly disagrees with these findings. CLICK HERE to watch a video and/or read his in-depth report debunking the study.
Finally, I was surprised to learn that an American has a 1 in 159 chance to develop multiple myeloma over the course of their lifetime. Doesn’t that seem high?
As Carol, a reader who forwarded me the information wrote: “Yikes!”
Feel good and keep smiling! Pat